XOMA Royalty (XOMA) Profit After Tax (QoQ) (2011 - 2026)
XOMA Royalty (XOMA) Profit After Tax (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.84% |
| Jun 30, 2025 | 288.30% |
| Mar 31, 2025 | 159.65% |
| Dec 31, 2024 | 76.99% |
| Sep 30, 2024 | -207.87% |
| Jun 30, 2024 | 285.98% |
| Mar 31, 2024 | 57.26% |
| Dec 31, 2023 | -265.02% |
| Sep 30, 2023 | -2.02% |
| Jun 30, 2023 | 44.97% |
| Mar 31, 2023 | -64.21% |
| Dec 31, 2022 | -43.03% |
| Sep 30, 2022 | 10.54% |
| Jun 30, 2022 | -104.82% |
| Mar 31, 2022 | -107.64% |
| Dec 31, 2021 | 772.77% |
| Sep 30, 2021 | -98.30% |
| Jun 30, 2021 | 69.66% |
| Mar 31, 2021 | -132.53% |
| Dec 31, 2020 | 2,204.55% |